Christmas cheer furthers fundraising efforts: Hosts Camille Ohmstede, left, and Sharon Parker are all smiles at the seventh annual Santa's Elves Party in Beaumont, Texas. Ohmstede and Parker welcomed nearly 100 guests to the festive fete benefiting MD Anderson's Camp Star Trails. Supporters raised over $33,000 for the camp, which hosts patients from MD Anderson Children's Cancer Hospital and their siblings, ages 5-12.
More Stories From Promise
Global ambassadors with a collective goal: Making Cancer History®
The MD Anderson Cancer Center Board of Visitors plays a significant role in advancing the institution as the world's premier cancer center.
My Moon Shot
Tom Rushing, of Houston, is a pancreatic cancer survivor of eight years. After his initial diagnosis, he sought a second opinion at MD Anderson and was placed in the care of Robert Wolff, M.D., chair ad interim, General Oncology; Sheikh Zayed Distinguished University Chair in Medical Oncology; and a co-leader of the Pancreatic Cancer Moon Shot. A senior consultant with Merrill Lynch, Rushing has been a member of the MD Anderson Cancer Center Board of Visitors since 2011, serving on the board's Development Committee.
About the Pancreatic Cancer Moon Shot
Learn more about the Pancreatic Cancer Moon Shot
The Moon Shots Program Overview
MD Anderson's Moon Shots Program is an unprecedented, comprehensive assault to significantly reduce cancer deaths and transform cancer care.
A lasting legacy
New York conservationist gives $30 million to cancer research
A Conversation With a Living Legend®
A signature event, steeped in tradition
Businesswoman, educator, philanthropist and sports enthusiast Nita Ambani, of Mumbai, India, joined the MD Anderson Cancer Center Board of Visitors in 2014. She is founder and chairperson of the Reliance Foundation, established in 2010 to provide impetus to various philanthropic initiatives of Reliance Industries Limited. The efforts of the group have touched the lives of more than 4 million people across India, in more than 5,500 villages and urban locations.
Judith Jennings, of Meridianville, Ala., is a mother, grandmother, retired teacher and ovarian cancer survivor.
A lifetime commitment
Life Members of the MD Anderson Cancer Center Board of Visitors embody philanthropy, leadership and a community spirit. Through their dedication and devotion, this select group has furthered MD Anderson's mission and advanced the institution toward its goal to end cancer. Their belief in MD Anderson has motivated their personal generosity and inspired that of others. True ambassadors of Making Cancer History®, they've helped place MD Anderson at the forefront of cancer care, research, prevention and education. In 2015, the board welcomed two new Life Members: Lyda Hill of Dallas and James A. Baker, III, of Houston.
Getting to know: David Herr
Call of the Cattlemen
Neighbors band together in the face of wildfires to support cancer research
Dancer to end cancer
Teen organizes flash mob in honor of grandparents
From football to philanthropy, she's "TUFF" enough
Katy league's Peyton Watson launches T-shirt sales to fight breast cancer
$50,000 boost to cancer prevention and control
Annual Halliburton Charity Golf Tournament supports MD Anderson
Pappas serves up $101,500 to #endcancer
Pappas Restaurants across Houston featured a unique opportunity on the menu this fall: the chance to help #endcancer.
Thumbs up for Stripes
Stripes® Convenience Stores gets the seal of approval from 4-year-old Caleb Sanchez, a patient at MD Anderson Children's Cancer Hospital.
MD Anderson receives $22.2 million in CPRIT grants
Funding underscores institution's excellence, impact
Researchers explore blood-based biopsy for pancreatic cancer
Prestigious honor recognizes outstanding contributions to oncology
Two MD Anderson scientists have earned membership in the American Association for the Advancement of Science (AAAS)
MAST + RECON
Study looks at factors such as cost, complications
Why some colorectal cancers recur after treatment
Study sheds new light on monoclonal antibody therapy cetuximab
Predictor of poor survival recurrence
Head and neck cancer research points to depression
Mark your calendar and join the fight